QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
LON:BMK

Benchmark (BMK) Share Forecast, Price & News

GBX 40
-2.80 (-6.54%)
(As of 06/8/2023 ET)
Compare
Today's Range
39.62
42.76
50-Day Range
34.60
44
52-Week Range
33
54
Volume
104,141 shs
Average Volume
357,129 shs
Market Capitalization
£295.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BMK stock logo

About Benchmark (LON:BMK) Stock

Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. The company operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass/bream, salmon, shrimp, and tilapia breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products, including Ectosan Vet and CleanTreat medicinal sea lice solutions to the aquaculture market. The company operates in the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, rest of the Europe, and internationally. Benchmark Holdings plc was founded in 2000 and is headquartered in Sheffield, the United Kingdom.

Receive BMK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Benchmark and its competitors with MarketBeat's FREE daily newsletter.

BMK Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
OMX Copenhagen Benchmark PI (OMXCBPI)
First new iPhone 14 reviews try to benchmark yellow
Master Market Movements: Free Stock Analysis Report with Predictive Buy/Sell/Hold Insights!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
China eHailing Platforms Benchmark Report 2022
Benchmark Holdings
Benchmark Holdings shares boosted by 'excellent' first half
Benchmark Holdings shares boosted by “excellent” first half
See More Headlines

BMK Price History

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
796
Year Founded
N/A

Profitability

Net Income
£-27,100,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£177.89 million
Cash Flow
GBX 5.40 per share
Book Value
GBX 40 per share

Miscellaneous

Free Float
N/A
Market Cap
£295.72 million
Optionable
Not Optionable
Beta
0.76

Key Executives

  • Mr. Trond Williksen (Age 60)
    CEO & Director
    Comp: $798.19k
  • Ms. Septima Maguire
    CFO & Director
  • Ms. Ruth Layton
    Co-Founder & Head of Benchmark Sustainability Science
  • Mr. Neil Robertson
    Head of Operations
  • Ms. Ivonne Maria Gloria Cantu (Age 54)
    Director of Investor Relations & Corp. Devel. and Head of Sustainability Working Group
  • Ms. Jennifer Haddouk
    Company Sec. & Group Legal Counsel
  • Ms. Corina Holmes
    Group Head of People
  • Mr. Roland James Bonney (Age 59)
    Group Lead of Key Account Management
  • Mr. David Babington
    Managing Director of Improve International
  • Mr. John Marshall
    Head of Health













BMK Stock - Frequently Asked Questions

How have BMK shares performed in 2023?

Benchmark's stock was trading at GBX 37 at the beginning of the year. Since then, BMK shares have increased by 8.1% and is now trading at GBX 40.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Benchmark own?
What is Benchmark's stock symbol?

Benchmark trades on the London Stock Exchange (LON) under the ticker symbol "BMK."

How do I buy shares of Benchmark?

Shares of BMK stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Benchmark's stock price today?

One share of BMK stock can currently be purchased for approximately GBX 40.

How much money does Benchmark make?

Benchmark (LON:BMK) has a market capitalization of £295.72 million and generates £177.89 million in revenue each year. The company earns £-27,100,000.00 in net income (profit) each year or GBX (0.04) on an earnings per share basis.

How many employees does Benchmark have?

The company employs 796 workers across the globe.

How can I contact Benchmark?

Benchmark's mailing address is Benchmark House, 8 Smithy Wood Drive, SHEFFIELD, S35 1QN, United Kingdom. The official website for the company is www.benchmarkplc.com. The company can be reached via phone at +44-114-2409935.

This page (LON:BMK) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -